CY1116513T1 - Piperidinone Derivatives as MDM2 Inhibitors for Cancer Therapeutic Treatment - Google Patents
Piperidinone Derivatives as MDM2 Inhibitors for Cancer Therapeutic TreatmentInfo
- Publication number
- CY1116513T1 CY1116513T1 CY20151100635T CY151100635T CY1116513T1 CY 1116513 T1 CY1116513 T1 CY 1116513T1 CY 20151100635 T CY20151100635 T CY 20151100635T CY 151100635 T CY151100635 T CY 151100635T CY 1116513 T1 CY1116513 T1 CY 1116513T1
- Authority
- CY
- Cyprus
- Prior art keywords
- therapeutic treatment
- cancer therapeutic
- mdm2 inhibitors
- piperidinone derivatives
- piperidinone
- Prior art date
Links
- 239000012819 MDM2-Inhibitor Substances 0.000 title abstract 3
- 239000012830 cancer therapeutic Substances 0.000 title 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical class O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 title 1
- 229940083338 MDM2 inhibitor Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει ενώσεις αναστολέων της MDM2 Τύπου (I), με τις σχετικές μεταβλητές να ορίζονται πιο πάνω, οι οποίες ενώσεις είναι χρήσιμες ως θεραπευτικοί παράγοντες, συγκεκριμένα για τη θεραπευτική αγωγή καρκίνων. Η παρούσα εφεύρεση σχετίζεται επίσης με φαρμακευτικές συνθέσεις που περιέχουν αναστολέα της MDM2.The present invention provides MDM2 inhibitor compounds of Formula (I), with the relevant variables defined above, which compounds are useful as therapeutic agents, in particular for the treatment of cancers. The present invention also relates to pharmaceutical compositions containing MDM2 inhibitor.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35182710A | 2010-06-04 | 2010-06-04 | |
| US35232210A | 2010-06-07 | 2010-06-07 | |
| US201161452578P | 2011-03-14 | 2011-03-14 | |
| EP20110726581 EP2576510B1 (en) | 2010-06-04 | 2011-06-03 | Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1116513T1 true CY1116513T1 (en) | 2017-03-15 |
Family
ID=58459759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100635T CY1116513T1 (en) | 2010-06-04 | 2015-07-17 | Piperidinone Derivatives as MDM2 Inhibitors for Cancer Therapeutic Treatment |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1116513T1 (en) |
-
2015
- 2015-07-17 CY CY20151100635T patent/CY1116513T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121265T1 (en) | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT | |
| CY1123626T1 (en) | HETEROCYCLIC PROTEIN KINASE INHIBITORS | |
| MX374513B (en) | HETEROARYL ACID MORPHOLINONE COMPOUNDS AS MDM2 INHIBITORS FOR CANCER TREATMENT. | |
| MX352672B (en) | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer. | |
| CY1119387T1 (en) | TRIAZOLOPYRAZINS AS BRD4 INHIBITORS FOR USE IN CANCER TREATMENT | |
| CY1122611T1 (en) | PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS | |
| EA201590879A1 (en) | ARYL-CONDENSED AND HETEROARYL-CONDENSED LACTAMS | |
| CO6321282A2 (en) | PIPERIDINYLINDOL DERIVATIVES AS INHIBITORS OF ALDOSTERONA SINTASA | |
| CY1119056T1 (en) | 2 ', 4', - DIFFluoro-2'-Methyl-Substituted Nucleoside Derivatization as HCV RNA Replication Inhibitors | |
| CR20110028A (en) | PIRIMIDINE DERIVATIVES AS CINASE INHIBITORS | |
| EA201590284A1 (en) | DIHYDROPYRIDON R1 AS INHIBITOR FACTOR XIA | |
| EA201590277A1 (en) | DIHYDROPYRIDON R1 AS INHIBITOR FACTOR XIA | |
| MX2012000711A (en) | Pyrrolopyrazine inhibitors of kinases. | |
| BR112012010186B8 (en) | heteroaryl derivatives containing n as jak3 kinase inhibitors and pharmaceutical composition comprising them | |
| CY1112465T1 (en) | AMINOTRIAZOL PRODUCTS AS ALX AGONISTS | |
| CO6362015A2 (en) | 1-AMINO-2CICLOBUTILETILBORONIC ACID DERIVATIVES | |
| CR20120641A (en) | MACROCYCLICAL COMPOUNDS AS QUINASA TRK INHIBITORS | |
| EA201170997A1 (en) | INDOL DERIVATIVES AS ANTI-TREATMENT AGENTS | |
| MX360330B (en) | Administration regime for nitrocatechols. | |
| MX2015010619A (en) | Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer. | |
| EA201270302A1 (en) | ANHARROUND FORMS OF PYRIDINE DERIVATIVES | |
| CY1120133T1 (en) | Pyridazines as DAAO Enzyme Inhibitors | |
| UY31775A (en) | HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS | |
| CY1116513T1 (en) | Piperidinone Derivatives as MDM2 Inhibitors for Cancer Therapeutic Treatment | |
| TR201902034T4 (en) | Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer diseases. |